CliffBio
small molecule

TIMENTIN

CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM

Loss of exclusivity—loss of exclusivity
CompanyGLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 2 LTD ENGLAND

Drug detail

Brand nameTIMENTIN
Active ingredientCLAVULANATE POTASSIUM; TICARCILLIN DISODIUM
StrengthEQ 100MG BASE/VIAL;EQ 3GM BASE/VIAL
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalDecember 1986
Marketing statusDISCN

More from GLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 2 LTD ENGLAND

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

TIMENTIN patent cliff — loss of exclusivity — | CliffBio